Pc3 Cells
Pc3 Cells - Related Videos
09:45
Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
0 Views •
2025
Circulating tumor cells (CTCs) are critical for the study of cancer progression and metastasis. This article presents a high-throughput, integrated protocol for CTC enrichment and single-CTC sequencing, improving capture efficiency and CTC purity while reducing contamination and sequencing costs, thereby advancing precision oncology research and clinical applications.
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
0 Views •
2025
This protocol describes the in vivo reprogramming of mouse cancer cells into type 1 dendritic-like cells within the tumor microenvironment through enforced expression of the transcription factors PU.1, IRF8, and BATF3.
22:06
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
0 Views •
Cited by 7 •
2007
This protocol details the derivation of transplantable hematopoietic stem cells from mouse embryonic stem cells (ESC) and their subsequent injection into lethally irradiated recipient mice. Briefly, ESC are differentiated as embryoid bodies, which are then infected with retroviral HoxB4 and co-cultured with OP9 stromal cells and hematopoietic cytokines.
02:47
Human ES cells: Starting Culture from Frozen Cells
0 Views •
2006
Here we demonstrate how our lab begins a HuES human embryonic stem cell line culture from a frozen stock.
10:54
Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
0 Views •
Cited by 2 •
2012
Metaphase to anaphase transition is triggered through anaphase-promoting complex (APC/C)-dependent ubiquitination and subsequent destruction of cyclin B. Here, we established a system which, following pulse-chase labeling, allows monitoring cyclin B proteolysis in entire cell populations and facilitates the detection of interference by the mitotic checkpoint.
FAQs
PC3 cells are especially useful when a study targets prostate cancer that no longer depends on androgen stimulation. Their low androgen receptor and prostate-specific antigen expression helps distinguish results from those obtained with hormone-responsive models. This makes them a relevant system for examining cellular behavior under an androgen-independent disease context, particularly when interpreting signaling, growth, or treatment responses.
Low expression of androgen receptor and prostate-specific antigen is not merely a descriptive feature; it helps define how findings should be interpreted. Responses observed in PC3 cultures cannot automatically be treated as responses of androgen-responsive prostate cancer cells. Comparing these cells with hormone-responsive models can therefore clarify whether an intervention acts in an androgen-independent context or depends on hormone-related characteristics.
Because the model supports analysis of signaling, proliferation, migration, and invasion, researchers can connect molecular interventions with several tumor-associated behaviors. A genetic or pharmacological change may be evaluated not only for its effect on cell growth but also for whether it alters movement or invasive capacity. This multi-behavior approach helps relate pathway activity to features associated with advanced disease.
The bone-metastatic origin gives PC3 cells a specific disease context for studies of advanced prostate cancer. It supports research questions centered on metastatic progression rather than only primary-tumor growth. When investigators examine migration or invasion in this model, those assays can be interpreted alongside the cell line's origin and androgen-independent phenotype, keeping the experimental question linked to disease progression.
At a general level, researchers maintain PC3 cells in culture, introduce a genetic or pharmacological intervention, and measure a selected tumor-associated behavior. The readout may focus on signaling, proliferation, migration, or invasion, depending on the research question. This workflow allows investigators to compare altered cultures with an appropriate experimental reference and determine whether the intervention changes the behavior under study.
Both genetic and pharmacological interventions can be examined in PC3-cell studies. Researchers use these approaches to test whether changing a gene or applying a drug alters signaling, cell proliferation, migration, or invasion. Drug-activity assays are particularly relevant to anticancer research, while genetic manipulation can help associate a molecular change with a tumor-associated outcome.
Their androgen-independent growth makes PC3 cells relevant to questions about disease that is not sustained by androgen stimulation. In that setting, investigators can assess how interventions affect proliferation, migration, invasion, or other measured responses and use the results to study anticancer drug activity. The model therefore contributes to research on therapeutic resistance alongside metastatic progression.